What Do We Know About Genomics and Alzheimer’s Disease?

What Do We Know About Genomics and Alzheimer’s Disease? is organized by International Society of Nurses in Genetics (ISONG).

Start Date: 17 Apr 2018
End Date: 16 Apr 2021

Who Should Attend?
Health care providers, educators, researchers, clinical staff working in geriatrics, students, family members of patients with Alzheimer's Disease, and anyone else interested in learning about the relationship between Alzheimer's and genomics.

Accreditation:
ISONG and ANA-NY are collaborating to provide this learning activity. Nurse participants completing the activity and the evaluation tool will receive one (1) continuing nursing education contact hour.

Description:
Providers and researchers will learn more about state of the science in Research and Guidelines. Current research focusing on the genomics of this disease will be described and discussed.

Objectives:
After this presentation attendees will know/learn:
• Review and update the pathophysiology of Alzheimer’s Disease (AD)
• Describe the genetic mutations/changes (including epigenetics, mitochondrial DNA and telomeres) associated with early onset and late onset AD.
• Explain known AD therapies and clinical trials for the treatment of this disorder.
• Discuss the role of the International Genomics Alzheimer’s Project (IGAP) in research.

Additional details will be posted as soon as information is available.